EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery

Shuai-Jiang Liu, Qian Zhao iD, Xiao-Chen Liu, Allan B Gamble, Wei Huang, Qian-Qian Yang, Bo Han

Medicinal Research Reviews · 2024-09 · 44 (5) · 1971-2014

DOI: 10.1002/med.22037 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 21.03.2024. Verfasst von Shuai-Jiang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, School of Basic Medical Sciences, Chengdu University of Traditio…. Hauptthemen laut MEDLINE: Drug Discovery, Drug Design. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 170 Literaturangaben. Gefördert von: New Zealand - China Non-Communicable Diseases Research Collaboration Centre (NCD CRCC) for funding., Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atropisomerism, an expression of axial chirality caused by limited bond rotation, is a prominent aspect within the field of medicinal chemistry. It has been shown that atropisomers of a wide range of compounds, including established FDA‐approved drugs and experimental molecules, display markedly different biological activities. The time‐dependent reversal of chirality in atropisomers poses complexity and obstacles in the process of drug discovery and development. Nonetheless, recent progress in understanding atropisomerism and enhanced characterization methods have greatly assisted medicinal chemists in the effective development of atropisomeric drug molecules. This article provides a comprehensive review of their special design thoughts, synthetic routes, and biological activities, serving as a reference for the synthesis and biological evaluation of bioactive atropisomers in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryDrug DesignStereoisomerismHumansAnimals

Stichwörter der Autor:innen

atropisomerismdesign strategiesrotational barrierstructure‐function relationshipsynthetic routes

Autor:innen und Institutionen

  • State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • School of Pharmacy, University of Otago, Dunedin, New Zealand.

ORCID-Profile: Qian Zhao

Förderung

  • New Zealand - China Non-Communicable Diseases Research Collaboration Centre (NCD CRCC) for funding.
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Liu, S. J., Zhao, Q., Liu, X. C., Gamble, A. B., Huang, W., Yang, Q. Q., & Han, B. (2024). Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery. Medicinal Research Reviews, 44(5), 1971-2014. https://doi.org/10.1002/med.22037

Vancouver

Liu SJ, Zhao Q, Liu XC, Gamble AB, Huang W, Yang QQ, et al. Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery. Medicinal Research Reviews. 2024;44(5):1971-2014. doi:10.1002/med.22037

BibTeX
@article{Liu2024,
  author = {Liu, Shuai-Jiang and Zhao, Qian and Liu, Xiao-Chen and Gamble, Allan B and Huang, Wei and Yang, Qian-Qian and Han, Bo},
  title = {Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery},
  journal = {Medicinal Research Reviews},
  year = {2024},
  volume = {44},
  number = {5},
  pages = {1971--2014},
  doi = {10.1002/med.22037}
}
Kostenlos starten →